Editorial
doi: 10.1016/j.eururo.2007.08.041.
Epub 2007 Aug 28.
Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials
- PMID: 17764823
- DOI: 10.1016/j.eururo.2007.08.041
Item in Clipboard
Editorial
Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials
Eur Urol.
2008 Jan.
No abstract available
Similar articles
-
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals.J Clin Oncol. 2005 Sep 1;23(25):6139-48. doi: 10.1200/JCO.2005.08.156. J Clin Oncol. 2005. PMID: 16135480
-
Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.Wien Klin Wochenschr. 2005 Jul;117(13-14):440-1. doi: 10.1007/s00508-005-0398-8. Wien Klin Wochenschr. 2005. PMID: 16091868 No abstract available.
-
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer.Nat Clin Pract Urol. 2005 Oct;2(10):482-91. doi: 10.1038/ncpuro0321. Nat Clin Pract Urol. 2005. PMID: 16474622 Review.
-
Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.Urology. 2007 Oct;70(4):702-5. doi: 10.1016/j.urology.2007.05.019. Urology. 2007. PMID: 17991541
-
Blood biomarkers for prostate cancer detection and prognosis.Future Oncol. 2007 Aug;3(4):449-61. doi: 10.2217/14796694.3.4.449. Future Oncol. 2007. PMID: 17661720 Review.
Cited by
-
Dynamic prediction of metastases after radical prostatectomy for prostate cancer.BJU Int. 2011 Dec;108(11):1762-8. doi: 10.1111/j.1464-410X.2011.10208.x. Epub 2011 May 26. BJU Int. 2011. PMID: 21615849 Free PMC article.
-
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):619-27. doi: 10.1158/1055-9965.EPI-10-1023. Epub 2011 Jan 25. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21266523 Free PMC article.
-
Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.BMC Cancer. 2010 Jun 10;10:277. doi: 10.1186/1471-2407-10-277. BMC Cancer. 2010. PMID: 20537166 Free PMC article.
-
Visceral disease in castration-resistant prostate cancer.Eur Urol. 2014 Feb;65(2):270-273. doi: 10.1016/j.eururo.2013.10.055. Epub 2013 Nov 22. Eur Urol. 2014. PMID: 24295792 Free PMC article.
-
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.J Urol. 2010 Jun;183(6):2213-8. doi: 10.1016/j.juro.2010.02.017. J Urol. 2010. PMID: 20399459 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
